Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-04ELVN144Heyman Richard A. plan to sell securities of Enliven Therapeutics, Inc. under Form 144MEDIUM
Heyman Richard A. filed Form 144 to notify SEC of plan to sell 38000 units of Enliven Therapeutics, Inc. securities around 2026-09-04, with aggregate market value of $2,252,830.00. The total outstanding units is 60904946.0. The amount planned to be sold represents 0.06% of total outstanding units; ...
Mid CapBiotechnology
2026-09-04DYN144Kerr Douglas plan to sell securities of Dyne Therapeutics, Inc. under Form 144MEDIUM
Kerr Douglas filed Form 144 to notify SEC of plan to sell 5000 units of Dyne Therapeutics, Inc. securities around 2026-09-04, with aggregate market value of $121,745.00. The total outstanding units is 186746431.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 m...
Mid CapBiotechnology